DWOAX
Price
$19.24
Change
+$0.20 (+1.05%)
Updated
Jul 31 closing price
Net Assets
1.64B
RGAEX
Price
$83.75
Change
+$0.96 (+1.16%)
Updated
Jul 31 closing price
Net Assets
356.86B
Interact to see
Advertisement

DWOAX vs RGAEX

DWOAX vs RGAEX Comparison Chart in %
View a ticker or compare two or three
VS
DWOAX vs. RGAEX commentary
Aug 03, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DWOAX is a Buy and RGAEX is a StrongBuy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RGAEX has more cash in the bank: 357B vs. DWOAX (1.64B). RGAEX pays higher dividends than DWOAX: RGAEX (0.22) vs DWOAX (0.00). DWOAX was incepted earlier than RGAEX: DWOAX (18 years) vs RGAEX (24 years). DWOAX (1.09) is less costly to investors than RGAEX (0.63). RGAEX is a more actively managed with annual turnover of: 32.00 vs. DWOAX (27.94). RGAEX has a lower initial minimum investment than DWOAX: RGAEX (250) vs DWOAX (1000). RGAEX annual gain was more profitable for investors over the last year : 1.44 vs. DWOAX (-5.69). RGAEX return over 5 years is better than : 13.05 vs. DWOAX (-11.74).
DWOAXRGAEXDWOAX / RGAEX
Total Expense Ratio1.000.63159%
Annual Report Gross Expense Ratio1.090.63173%
Fund Existence18 years24 years-
Gain YTD-1.7365.572-31%
Front Load6%N/A-
Min. Initial Investment1000250400%
Min. Initial Investment IRAN/AN/A-
Net Assets1.64B357B0%
Annual Yield % from dividends0.000.22-
Returns for 1 year-5.691.44-394%
Returns for 3 years22.4735.5463%
Returns for 5 years-11.7413.05-90%
Returns for 10 years33.4698.8434%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
MSELX15.130.32
+2.16%
Morgan Stanley Inst Emerging Mkts L
JHDFX21.390.15
+0.71%
JPMorgan Hedged Equity 2 R5
VSMPX336.321.92
+0.57%
Vanguard Morn Total Stk Mkt Idx Instl Pl
SCYVX17.890.05
+0.28%
AB Small Cap Value Advisor
PCHSX35.73-0.25
-0.69%
Putnam Global Health Care C